On July 13, 2012, the Ethics Committee reviewed our responses to its initial rejection of the protocol for our proposed Australian study of MDMA-assisted psychotherapy for PTSD, to be co-sponsored by the …
MAPS is working with an Australian non-profit organization, Psychedelic Research in Science and Medicine (PRISM), to obtain approval for a new Australian study of MDMA-assisted psychotherapy for PTSD. …
MAPS is working with an Australian non-profit organization, Psychedelic Research in Science and Medicine (PRISM), to obtain approval for a new Australian study of MDMA-assisted psychotherapy for PTSD. …
On February 22, 2012, an Australian ethics committee rejected the protocol for our planned Australian study of MDMA-assisted psychotherapy for PTSD. The committee raised issues relating to study design …
On February 22, 2012, an Australian ethics committee rejected the protocol for our planned Australian study of MDMA-assisted psychotherapy for PTSD. The committee raised issues relating to study design …
On February 7, 2012, the protocol for our planned Australian study of MDMA-assisted psychotherapy for PTSD was submitted to an independent Human Research Ethics Committee (HREC). Subjects in this study …
On February 7, 2012, the protocol for our planned Australian study of MDMA-assisted psychotherapy for PTSD was submitted to an independent Human Research Ethics Committee (HREC). Subjects in this study …
On January 8, 2012, our clinical team finalized the basic design of the protocol for our planned Australian study of MDMA-assisted psychotherapy for PTSD. The study, which will be led by Clinical Investigators …
